Cost of illness for outpatients attending public and private hospitals in Bangladesh

Pavel, Md Sadik and Chakrabarty, Sayan and Gow, Jeff (2015): Cost of illness for outpatients attending public and private hospitals in Bangladesh. Published in: International Journal for Equity in Health , Vol. 167, No. 15 (10 October 2016): pp. 1-12.

Abstract

Background A central aim of Universal Health Coverage (UHC) is protection for all against the cost of illness. In a low income country like Bangladesh the cost burden of health care in tertiary facilities is likely to be significant for most citizens. This cost of an episode of illness is a relatively unexplored policy issue in Bangladesh. The objective of this study was to estimate an outpatient’s total cost of illness as result of treatment in private and public hospitals in Sylhet, Bangladesh.

Methods The study used face to face interviews at three hospitals (one public and two private) to elicit cost data from presenting outpatients. Other socio-economic and demographic data was also collected. A sample of 252 outpatients were randomly selected and interviewed. The total cost of outpatients comprises direct medical costs, non-medical costs and the indirect costs of patients and caregivers. Indirect costs comprise travel and waiting times and income losses associated with treatment.

Results The costs of illness are significant for many of Bangladesh citizens. The direct costs are relatively minor compared to the large indirect cost burden that illness places on households. These indirect costs are mainly the result of time off work and foregone wages. Private hospital patients have higher average direct costs than public hospital patients. However, average indirect costs are higher for public hospital patients than private hospital patients by a factor of almost two. Total costs of outpatients are higher in public hospitals compared to private hospitals regardless of patient’s income, gender, age or illness.

Conclusion Overall, public hospital patients, who tend to be the poorest, bear a larger economic burden of illness and treatment than relatively wealthier private hospital patients. The large economic impacts of illness need a public policy response which at a minimum should include a national health insurance scheme as a matter of urgency.

• Item Type: MPRA Paper
• Language: English
• Keywords: Total cost of outpatients, Direct cost, Indirect cost, Health care, Public vs private, Bangladesh
• Subjects: I - Health, Education, and Welfare > I1 - Health; I - Health, Education, and Welfare > I1 - Health > I11 - Analysis of Health Care Markets; I - Health, Education, and Welfare > I1 - Health > I13 - Health Insurance, Public and Private; I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health

References

References Adams AM. Charting a course through the jungle of urban healthcare delivery in Bangladesh. Health System Global (HSG) 2016. http://www.healthsystemsglobal.org/blog/112/Charting-a-Course-Through-the-Jungle-of-Urban-Healthcare-Delivery-in-Bangladesh.html. Accessed 28th May 2016.

Ahmed S and Khan M. A maternal health voucher scheme: what have we learned from the demand side financing scheme in Bangladesh? Heal Pol Plan 2011; 26:25-32. Babu BV, Nayak AN et al. The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India. Acta Tropica 2002; 82(1):31-38.

Bangladesh Bureau of Statistics. Household Income and Expenditure Survey Report 2010. Statistics and Informatics Division, Ministry of Planning, Government of Bangladesh (GoB), 2014. http://www.bbs.gov.bd/WebTestApplication/userfiles/Image/LatestReports/HIES-10.pdf. Accessed 4th Nov 2015.

Balabanova D, McKee M. Understanding informal payments for health care: the example of Bulgaria. Heal Pol 2002; 62(3):243-273.

Bitran R. Explicit health guarantees for Chileans: The AUGE benefits package. UNICO Studies Series No. 21 2013; World Bank, Washington DC. http://documents.worldbank.org/curated/en/2013/01/17207311/explicit-health-guarantees-chileans-auge-benefits-package. Accessed 4th Nov 2015.

Boccuzzi SJ. Indirect health care costs. Chapter in Cardiovascular Health Care Economics Weintraub W.S. (ed.) Springer, New York, 2003; 63-79.

Byford S, Torgerson DJ, Raftery J. Cost of illness studies. BMJ 2000; 320 (7245):1335. Chima RI, Goodman CA et al. The economic impact of malaria in Africa: a critical review of the evidence. Heal Pol 2003; 63(1):17-36.

Chowdhury AMR, Bhuiya A et al. The Bangladesh paradox: exceptional health achievement despite economic poverty. Lancet 2013; 382(9906):1734-1745.

Chuma J, Gilson L, Molyneux C. Treatment-seeking behaviour, cost burdens and coping strategies among rural and urban household in Coastal Kenya: an equity analysis. Trop Med Int Health 2007; 12(5):673-686.

Desmet M, Chowdhury AQ, Islam MK. The potential for social mobilisation in Bangladesh: the organisation and functioning of two health insurance schemes. Soc Sci Med 1999; 48: 925-938.

Directorate General of Health Services (DGHS): Health services through mobile phone. Dhaka, Bangladesh 2015. Available at: http://www.dghs.gov.bd/index.php/en/e-health/our-ehealth-eservices/84-english-root/ehealth-eservice/105-health-service-through-mobile-phone. Accessed 4th Nov 2015.

Giedion U, Alfonso EA, Díaz Y. The impact of universal coverage schemes in the developing world: A review of the existing evidence. UNICO Studies Series No. 25 2013; World Bank, Washington DC. http://documents.worldbank.org/curated/en/2013/01/17291221/impact-universal-coverage-schemes-developing-world-review-existing-evidence. Accessed 4th Nov 2015.

Gold MR, Siegel JE et al. Cost-effectiveness in health and medicine. Oxford University Press 1996; New York, USA.

Goossens MEJB, Mölken MPMH et al. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53(7):688-695.

Griffin CC. Health Care in Asia. A Comparative Study of Cost and Financing. World Bank Regional and Sectoral Studies, 1992, The World Bank, Washington.

Hodgson TA, Meiners MR. Cost-of-illness methodology: A guide to current practices and procedures. Heal Soc 1982; 60(3):429-462.

Huda T, Khan JAM et al. Monitoring and Evaluating Progress towards Universal Health Coverage in Bangladesh. PLoS Med 2014; 11(9).

Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol 2014; 20(4):327-337.

Koopmanschap MA, Rutten FFH et al. The friction cost method for measuring indirect costs of disease. J Heal Econ 1995; 14(2):171-189.

McIntyre D, Thiede M et al. What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Soc Sci Med 2006; 62(4):858-865.

Pavel MS, Chakrabarty S, Gow J. Assessing willingness to pay for healthcare quality improvements. BMC Health Serv Res 2015; 15(43).

Pavel MS. Bangladesh pharmaceutical industry won’t be ready to implement TRIPS by 2016. The Financial Express 2012, Dhaka, Bangladesh. http://print.thefinancialexpress-bd.com/old/more.php?news_id=130487&date=2012-05-23. Accessed 28th May 2016.

Poulos C, Riewpaiboon A et al. Costs of illness due to endemic cholera. Epidemiol Infect 2011; 140(3):500-509.

Rice DP. Cost of illness studies: what is good about them? Injury Prevent 2000; 6:177-179.

Russell S. The economic burden of illness for households in developing countries: A review of studies focusing on Malaria, Tuberculosis, and Human Immunodeficiency virus/ acquired immunodeficiency syndrome. Am J Trop Med Hyg 2004; 71(2):147-155.

Sakdapolrak P, Seyler T, Ergler C. Burden of direct and indirect cost of illness: Empirical findings from slum settlements in Chennai, South India. Progr Develop Studies 2013; 13(2):135-151.

Sarker AR, Islam Z et al. Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective. BMC Infect Dis 2013; 13:518.

Sauerborn R, Adams A, Hien M. Household strategies to cope with the economic costs of illness. Soc Sci Med 1996; 43 (3): 291-301.

The World Health Organization (WHO). The world health report-health system: improving performance. Geneva, Switzerland, 2000. http://www.who.int/whr/2000/en/. Accessed 4th Nov 2015.

The World Health Organization (WHO). World Health Report: Health System Financing- The Path to Universal Coverage. Geneva, Switzerland, 2010. http://www.who.int/whr/2010/10_summary_en.pdf. Accessed 4th Nov 2015.

Torres FM. Costa Rica case study: Primary health care achievements and challenges within the frame of the social health insurance. UNICO Studies Series No. 14 2013; World Bank, Washington DC. http://documents.worldbank.org/curated/en/2013/01/17207456/costa-rica-case-study-primary-health-care-achievements-challenges-within-framework-social-health-insurance. Accessed 4th Nov 2015.

Van Doorslaer EV, O’Donnell O et al. Paying out-of-pocket for health care in Asia: catastrophic and poverty impact. Working paper No. 2 2005; EQUITAP Project. http://www.eldis.org/go/home&id=24169&type=Document#.Vga7vxKqqko. Accessed 04 Nov 2015.

Woolley H, Mushkin SJ et al. Cost of disease and illness in the United States in the year 2000. Pub Heal Rep 1978; 93(5):493-588.

Xu K, Evans DB et al. Protecting household from catastrophic health spending. Health Affairs 2007; 26(4):972-983.

Yadav P. Health Product Supply Chains in Developing Countries: Diagnosis of the Root Causes of Underperformance and an Agenda for Reform. Heal Syst Reform 2015; 1(2):142-154.